Global & Public Health (all articles)
Review: Characteristics of SARS-CoV-2 and COVID-19
12 Oct, 2020 | 00:49h | UTCCharacteristics of SARS-CoV-2 and COVID-19 – Nature Reviews Microbiology
Commentary on Twitter
Characteristics of SARS-CoV-2 and COVID-19
Zheng-Li Shi et al. summarize the exceptional amount of research that has characterized SARS-CoV-2 and COVID-19, discussing the emergence and virology of SARS-CoV-2 and the pathogenesis and treatment of COVID-19https://t.co/kGL6nOdOYu pic.twitter.com/1ePqHvLxFz
— Nature Reviews Microbiology (@NatureRevMicro) October 6, 2020
Follow-up of adults with non-critical COVID-19 two months after symptoms’ onset
12 Oct, 2020 | 00:44h | UTCCommentary: Even Mild Covid-19 Infections Can Make People Sick for Months – Bloomberg
Commentary on Twitter
Follow-up of adults with non-critical COVID-19 two months after symptoms' onset – Clinical Microbiology and Infection Two thirds of adults with non-critical COVID-19 had persistent symptoms up to 2 months after symptom onset. https://t.co/xZk2DURyTG
— Carlos del Rio (@CarlosdelRio7) October 10, 2020
New test detects coronavirus in just 5 minutes
12 Oct, 2020 | 00:39h | UTCNew test detects coronavirus in just 5 minutes – Science
Researchers face hurdles to evaluate, synthesize COVID-19 evidence at top speed
12 Oct, 2020 | 00:37h | UTCResearchers face hurdles to evaluate, synthesize COVID-19 evidence at top speed – Science
Opinion: Schools aren’t super-spreaders
12 Oct, 2020 | 00:40h | UTCSchools Aren’t Super-Spreaders – Atlantic
CDC Study: Factors influencing risk for COVID-19 exposure among young adults aged 18–23 years
12 Oct, 2020 | 00:36h | UTC
Commentary on Twitter
Young adults have several factors influencing their risk of being exposed to #COVID19, including perceived low severity of disease outcome and exposure to conflicting messages about the need for and effectiveness of masks, according to new @CDCMMWR. https://t.co/1mNNDrbLCi pic.twitter.com/8hf2F70bZH
— CDC (@CDCgov) October 9, 2020
Transmission dynamics by age group in COVID-19 hotspots in US
12 Oct, 2020 | 00:35h | UTC
Commentary on Twitter
A @CDCMMWR finds percentage of positive #COVID19 tests in hotspot counties went up first in younger adults, then in older adults who may be at higher risk. The report highlights the need to reduce the spread of #COVID19 among younger adults. More: https://t.co/MnHYfZzY7c pic.twitter.com/Y6WaZbB6MH
— MMWR (@CDCMMWR) October 9, 2020
RECOVERY trial: Effect of hydroxychloroquine in hospitalized patients with Covid-19
9 Oct, 2020 | 09:15h | UTC
AHA Scientific Statement: Assessing and addressing cardiovascular health in LGBTQ adults
12 Oct, 2020 | 00:29h | UTCNews Release: Discrimination contributes to poorer heart health for LGBTQ adults – American Heart Association
Commentary: Improving the Cardiovascular Health of the LGBTQ Community: An Urgent Call to Action
Top Things to Know: Assessing and Addressing Cardiovascular Health in LGBTQ Adults
Remdesivir for the treatment of Covid-19 — final report
9 Oct, 2020 | 09:13h | UTCRemdesivir for the Treatment of Covid-19 — Final Report – New England Journal of Medicine
Commentary: BREAKING NEWS: Final remdesivir results published after 139 days of waiting – Brief19
Commentary on Twitter
📍Remdesivir trial (ACTT-1) final results finally out.
📍Still no mortality benefit. A study with tons of patients could show some small mortality benefit.
📍Those who recover, do so a bit faster.
📍Not the game-changer that was hyped.via @Brief_19https://t.co/jWRJypJIuS
— Jeremy Faust MD MS (ER physician) (@jeremyfaust) October 8, 2020
[News release – not published yet] Eli Lilly says its monoclonal antibody cocktail is effective in treating Covid-19
9 Oct, 2020 | 09:09h | UTCEli Lilly says its monoclonal antibody cocktail is effective in treating Covid-19 – STAT
Perspective – Coronavirus: Is the cure worse than the disease? The most divisive question of 2020
9 Oct, 2020 | 09:06h | UTC
As we fight the coronavirus pandemic, we cannot ignore non-communicable diseases
9 Oct, 2020 | 09:08h | UTCAs We Fight The Coronavirus Pandemic, We Cannot Ignore Non-Communicable Diseases – Forbes
The facts about herd immunity and COVID-19
9 Oct, 2020 | 09:01h | UTCThe Facts About Herd Immunity and COVID-19 – Medium
Why herd immunity strategy is regarded as fringe viewpoint
9 Oct, 2020 | 09:03h | UTCWhy herd immunity strategy is regarded as fringe viewpoint – The Guardian
Coronavirus: Health experts join global anti-lockdown movement
9 Oct, 2020 | 09:00h | UTCCoronavirus: Health experts join global anti-lockdown movement – BBC
WHO/UNICEF Report – Neglected Tragedy: The Global Burden of Stillbirths
9 Oct, 2020 | 08:54h | UTCNeglected Tragedy: The Global Burden of Stillbirths – World Health Organization / UNICEF
News Release: One stillbirth occurs every 16 seconds, according to first ever joint UN estimates – World Health Organization
Commentary on Twitter
According to 🆕 estimates, almost 2 million babies are stillborn every year – or 1 #stillbirth every 16 seconds.
#COVID19 related health service disruptions could worsen the situation, potentially adding 200,000 more stillbirths over a 12-month period:
👉https://t.co/vgD9SJSzCK pic.twitter.com/4fFAlbrIjj— World Health Organization (WHO) (@WHO) October 8, 2020
Randomized trial: Effect of exercise training for five years on all cause mortality in older adults
9 Oct, 2020 | 08:56h | UTCNews Release: Exercise intensity not linked to mortality risk in older adults, finds trial – BMJ
Infographic: Generation 100 study: randomised controlled trial
Commentary: It’s never too late for older adults to start exercising – The BMJ Opinion
Commentaries on Twitter
Impressive study — 5yr #exercise RCT looking at all cause mortality in over 1500 older adults (~73yo). Adherence to exercise ~50%. @bmj_latest https://t.co/UnthYld2bM pic.twitter.com/t4JMQXiD78
— Jess Scott, PhD (@cardiac_fitness) October 8, 2020
Exercise intensity appears to make no difference to risk of mortality among older adults, suggests a randomised controlled trial from Norway published by @bmj_latest today https://t.co/7h7hzPTymf @UWisloff
— BMJ Group (@bmj_company) October 8, 2020
Editorial – Long COVID: let patients help define long-lasting COVID symptoms
8 Oct, 2020 | 09:09h | UTCLong COVID: let patients help define long-lasting COVID symptoms – Nature
Outcomes of sailors in isolation after a COVID-19 outbreak on a US aircraft carrier
8 Oct, 2020 | 09:13h | UTC
Commentary on Twitter
(1/3) Study of the #COVID19 outbreak on the USS Theodore Roosevelt aircraft carrier, with follow-up of outcomes. 736 sailors with a median age of 25 years were infected. 20% were asymptomatic, 1% were hospitalised, and 0.1% died.https://t.co/BMGZYUl7s1 pic.twitter.com/pm1gFJB0BE
— Dr Zoë Hyde (@DrZoeHyde) October 4, 2020
What is post-viral fatigue syndrome, the condition affecting some COVID-19 survivors?
8 Oct, 2020 | 09:08h | UTC
5 things to know about a COVID vaccine: It won’t be a ‘magic wand’
8 Oct, 2020 | 09:05h | UTC5 Things to Know About a COVID Vaccine: It Won’t Be a ‘Magic Wand’ – Kaiser Health News
Why people with diabetes are being hit so hard by Covid-19
8 Oct, 2020 | 09:04h | UTCWhy people with diabetes are being hit so hard by Covid-19 – STAT
Covid-19: People are gathering again, but can crowds be made safe?
8 Oct, 2020 | 09:01h | UTCCovid-19: People are gathering again, but can crowds be made safe? – The BMJ
How the leading coronavirus vaccines work
8 Oct, 2020 | 09:06h | UTCHow the leading coronavirus vaccines work – The Conversation
Related: SARS-CoV-2 Vaccine Development: Current Status – Mayo Clinic Proceedings